EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex

被引:14
作者
Bullerwell, Charles E. [1 ]
Robichaud, Philippe Pierre [1 ,2 ]
Deprez, Pierre M. L. [1 ]
Joy, Andrew P. [1 ]
Wajnberg, Gabriel [1 ]
D'Souza, Darwin [1 ,3 ]
Chacko, Simi [1 ]
Fournier, Sebastien [1 ]
Crapoulet, Nicolas [1 ]
Barnett, David A. [1 ,2 ]
Lewis, Stephen M. [1 ,2 ]
Ouellette, Rodney J. [1 ,2 ]
机构
[1] Atlantic Canc Res Inst, Pavillon Hotel Dieu,35 Providence St, Moncton, NB E1C 8X3, Canada
[2] Univ Moncton, Dept Chem & Biochem, Moncton, NB, Canada
[3] Ctr Appl Genom, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
TRANSCRIPTION FACTOR; CHROMOSOMAL TRANSLOCATION; TARGET GENES; BRCT-DOMAIN; REPRESSION; PROTEIN; BSAP; ACTIVATION; PTIP; IDENTIFICATION;
D O I
10.1038/s41598-021-81000-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
PAX5 and EBF1 work synergistically to regulate genes that are involved in B lymphocyte differentiation. We used the KIS-1 diffuse large B cell lymphoma cell line, which is reported to have elevated levels of PAX5 expression, to investigate the mechanism of EBF1- and PAX5-regulated gene expression. We demonstrate the lack of expression of hallmark B cell genes, including CD19, CD79b, and EBF1, in the KIS-1 cell line. Upon restoration of EBF1 expression we observed activation of CD19, CD79b and other genes with critical roles in B cell differentiation. Mass spectrometry analyses of proteins co-immunoprecipitated with PAX5 in KIS-1 identified components of the MLL H3K4 methylation complex, which drives histone modifications associated with transcription activation. Immunoblotting showed a stronger association of this complex with PAX5 in the presence of EBF1. Silencing of KMT2A, the catalytic component of MLL, repressed the ability of exogenous EBF1 to activate transcription of both CD19 and CD79b in KIS-1 cells. We also find association of PAX5 with the MLL complex and decreased CD19 expression following silencing of KMT2A in other human B cell lines. These data support an important role for the MLL complex in PAX5-mediated transcription regulation.
引用
收藏
页数:14
相关论文
共 49 条
  • [31] The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells
    McManus, Shane
    Ebert, Anja
    Salvagiotto, Giorgia
    Medvedovic, Jasna
    Sun, Qiong
    Tamir, Ido
    Jaritz, Markus
    Tagoh, Hiromi
    Busslinger, Meinrad
    [J]. EMBO JOURNAL, 2011, 30 (12) : 2388 - 2404
  • [32] Pax5: A Master Regulator of B Cell Development and Leukemogenesis
    Medvedovic, Jasna
    Ebert, Anja
    Tagoh, Hiromi
    Busslinger, Meinrad
    [J]. ADVANCES IN IMMUNOLOGY, VOL 111, 2011, 111 : 179 - 206
  • [33] CD40 stimulation induces Pax5/BSAP and EBF activation through a APE/ref-1-dependent redox mechanism
    Merluzzi, S
    Moretti, M
    Altamura, S
    Zwollo, P
    Sigvardsson, M
    Vitale, G
    Pucillo, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (03) : 1777 - 1786
  • [34] PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements
    Mi, Huaiyu
    Huang, Xiaosong
    Muruganujan, Anushya
    Tang, Haiming
    Mills, Caitlin
    Kang, Diane
    Thomas, Paul D.
    [J]. NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) : D183 - D189
  • [35] A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes
    Milili, M
    Gauthier, L
    Veran, J
    Mattei, MG
    Schiff, C
    [J]. IMMUNOLOGY, 2002, 106 (04) : 447 - 455
  • [36] Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma
    Morrison, AM
    Jäger, U
    Chott, A
    Schebesta, M
    Haas, OA
    Busslinger, M
    [J]. BLOOD, 1998, 92 (10) : 3865 - 3878
  • [37] CD30: from basic research to cancer therapy
    Muta, Hiromi
    Podack, Eckhard R.
    [J]. IMMUNOLOGIC RESEARCH, 2013, 57 (1-3) : 151 - 158
  • [38] Loss of Pax5 promotes plasma cell differentiation
    Nera, KP
    Kohonen, P
    Narvi, E
    Peippo, A
    Mustonen, L
    Terho, P
    Koskela, K
    Buerstedde, JM
    Lassila, O
    [J]. IMMUNITY, 2006, 24 (03) : 283 - 293
  • [39] A statistical model for identifying proteins by tandem mass spectrometry
    Nesvizhskii, AI
    Keller, A
    Kolker, E
    Aebersold, R
    [J]. ANALYTICAL CHEMISTRY, 2003, 75 (17) : 4646 - 4658
  • [40] Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments
    Nutt, SL
    Morrison, AM
    Dörfler, P
    Rolink, A
    Busslinger, M
    [J]. EMBO JOURNAL, 1998, 17 (08) : 2319 - 2333